Specialized genetic tests

Manufacturing - Drug Substance

Glo-Fusionis a next-generation bioprocessing strategy that integrates upstream perfusion with downstream purification in a seamless, continuous flow. It delivers transformative improvements in productivity, cost-efficiency, and sustainability.

Key Differentiators

  • Commercial-scale output of 5-50 kg/month from a 2000- 3000 ft² facility
  • Up to 10× higher volumetric productivity
  • 40–50% lower cost per gram of protein
  • Lower CapEx and reduced cost of goods
  • Reduced carbon footprint via compact design and efficient operation
  • Longer runtime and higher suite occupancy
  • Flexible Scale-ON and Scale-OUT options
  • Product quality with improved stability

Sustainability & Innovation

  • Smaller equipment footprint
  • Lower energy consumption
  • Fewer cleaning cycles and waste streams
back top